Cargando…
In vitro inhibitory activities of magnolol against Candida spp.
Candida spp. cause various infections involving the skin, mucosa, deep tissues, and even life-threatening candidemia. They are regarded as an important pathogen of nosocomial bloodstream infection, with a high mortality rate. As a result of prolonged exposure to azoles, the therapeutic failure assoc...
Autores principales: | Zhou, Peiru, Fu, Jingya, Hua, Hong, Liu, Xiaosong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593404/ https://www.ncbi.nlm.nih.gov/pubmed/28919715 http://dx.doi.org/10.2147/DDDT.S146529 |
Ejemplares similares
-
In vitro Antifungal Effects of Berberine Against Candida spp. In Planktonic and Biofilm Conditions
por: Xie, Yufei, et al.
Publicado: (2020) -
Magnolol as a potent antifungal agent inhibits Candida albicans virulence factors via the PKC and Cek1 MAPK signaling pathways
por: Xie, Yufei, et al.
Publicado: (2022) -
In Vitro and In Vivo Inhibitory Activity of Limonene against Different Isolates of Candida spp.
por: Muñoz, Julián E., et al.
Publicado: (2020) -
Lactobacillus fermentum ATCC 23271 Displays In vitro Inhibitory Activities against Candida spp.
por: do Carmo, Monique S., et al.
Publicado: (2016) -
Inhibitory effects of magnolol and honokiol on human calcitonin aggregation
por: Guo, Caiao, et al.
Publicado: (2015)